24 May 2013
Keywords: Ares Life Sciences, Albion Medical, GREER Laboratories, M&A, Allergy immunotherapies, Stallergenes, Oralair
Article | 08 March 2013
Ares Life Sciences says it has signed a definitive agreement to acquire 100% of the share capital of Albion Medical Holdings, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.